PISSA, Maria et al. CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015–2020: implications for novel national recommendations. Acta Oncologica, [S. l.], v. 60, n. 7, p. 888–896, 2021. DOI: 10.1080/0284186X.2021.1914346. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/23994. Acesso em: 26 feb. 2025.